THE PRESENT INVENTION RELATES TO A SOLID ORAL DOSAGE FORM COMPRISING A THERAPEUTICALLY EFFECTIVE AMOUNT OF ALISKIREN OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, A THERAPEUTICALLY EFFECTIVE AMOUNT OF HCTZ AND A HYDROPHILIC FILLER SELECTED FROM THE GROUP A CARBOHYDRATE OR COMBINATIONS THEREOF, E.G. SUGARS, SUGAR ALCOHOLS AND STARCHES OR COMBINATIONS OF THESE.